Skip to Navigation
Home
The Cochrane Collaboration
Working together to provide the best evidence for health care
to The Cochrane Library
Logo of the Cochrane twentieth anniversary website
  • Home
  • About us
  • Cochrane Reviews
  • News & Events
  • Training
  • Multimedia
  • Contact
  • Community
Home › Cochrane Policy Manual › 3. OPERATIONS › 3.2 Cochrane Review Groups › 3.2.6 Maintaining and managing a Cochrane Review Group

See the latest changes to the Policy Manual

3.2.6 Maintaining and managing a Cochrane Review Group

Subheadings in this section

  • 3.2.6.1 Establishing a refereeing policy
  • 3.2.6.2 Policy on default statistics
  • 3.2.6.3 Non-performance of authors
  • 3.2.6.4 Avoiding duplication of reviews and protocols
  • 3.2.6.5 Internal Cochrane Review Group policies
  • 3.2.6.6 Dealing with conflicts within Groups
  • 3.2.6.7 Liaising with Fields and Methods Groups
  • 3.2.6.8 Maintaining an active list of authors and other contributors
  • 3.2.6.9 Producing a newsletter
  • 3.2.6.10 Reviewing the scope of the Cochrane Review Group
  • 3.2.6.11 Performance and quality assessment of Cochrane Review Groups
‹ 3.2.5.5 Planning funding up 3.2.6.1 Establishing a refereeing policy ›
  • Generate PDF of this section (this process may take a few minutes)

Download The Cochrane Policy Manual in PDF format.
Attention
: Please note that this PDF version is generated nightly and thus may not reflect changes made in the last 24 hours.

Updated on: February 29, 2012, 12:56

Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
Email: web@cochrane.org

Navigation

  • 1. CENTRAL ORGANISATION
    • 1.1 Description of The Cochrane Collaboration
      • 1.1.1 The Cochrane Operations Unit
      • 1.1.2 Editor in Chief/Cochrane Editorial Unit
        • 1.1.2.1 Cochrane Library Oversight Committee
      • 1.1.3 Special roles within The Cochrane Collaboration (with job descriptions)
        • 1.1.3.1 Co-Chairs of the Steering Group
        • 1.1.3.2 Members of the Steering Group
        • 1.1.3.3 Company Secretary
        • 1.1.3.4 Funding Arbiter
          • 1.1.3.4.1 Referrals to the Funding Arbiter
        • 1.1.3.5 Ombudsmen
        • 1.1.3.6 Publication Arbiter
        • 1.1.3.7 Trading Company Directors
        • 1.1.3.8 Cochrane Innovations Limited
        • 1.1.3.9 Treasurer
        • 1.1.3.10 CRG executives
          • 1.1.3.10.1 Co-ordinating Editors' Executive - terms of reference
          • 1.1.3.10.2 Managing Editors' Executive - remit
        • 1.1.3.11 Trials Search Co-ordinators' Executive - Remit
        • 1.1.3.12 Methods Board and Methods Executive
          • 1.1.3.12.1 Methods Board - remit and membership
          • 1.1.3.12.2 Methods Executive - remit and membership
        • 1.1.3.13 Fields' Executive
        • 1.1.3.14 Consumers' Executive
      • 1.1.4 Core infrastructure: expectations of budget holders
    • 1.2 Strategic Plan
      • 1.2.1 Goals and objectives
    • 1.3 Memorandum and Articles of Association
    • 1.4 Communication
      • 1.4.1 Websites
      • 1.4.2 Mailing lists
      • 1.4.3 The Collaboration’s Information Management System - Archie
      • 1.4.4 Archie - Terms of use
      • 1.4.5 Criteria for inclusion in Archie and/or access to the Entity Website Builder
      • 1.4.6 Permission to access Collaboration-wide data in Archie
      • 1.4.7 Newsletters
      • 1.4.8 Guidelines for sending e-mail attachments
      • 1.4.9 Cross-cultural team working within The Cochrane Collaboration
    • 1.5 Support
      • 1.5.1 Principles governing sources of support
      • 1.5.2 Declarations of interest
      • 1.5.3 Discretionary Fund
  • 2. COCHRANE COLLABORATION POLICIES
    • 2.1 General policies
      • 2.1.1 Code of conduct for avoiding potential financial conflicts of interest
        • 2.1.1.1 General principle
        • 2.1.1.2 Policy
      • 2.1.2 Avoidance of conflict of interest in reimbursing Steering Group expenses
      • 2.1.3 Criteria for choosing the location of mid-year meetings of the Steering Group, Centre Directors, Entity Executives and related others
      • 2.1.4 Cochrane Colloquia
        • 2.1.4.1 Standard operating procedures for Cochrane Colloquia
        • 2.1.4.2 General criteria for Cochrane Colloquia sponsorships
        • 2.1.4.3 Process for selecting the location of Cochrane Colloquia
      • 2.1.5 Registering surveys with the Cochrane Operations Unit (COU)
      • 2.1.6 Country names in Cochrane publications
      • 2.1.7 Policy on indirect overhead costs
      • 2.1.8 Policy on the granting of endorsements
        • Annex 2.1.8.A - checklist for assessing applications for endorsement
        • Annex 2.1.8.B - Decision table
      • 2.1.9 Appointment of a proxy to attend a Steering Group meeting
      • 2.1.10 Partnership policy of The Cochrane Collaboration
      • 2.1.11 Inflation Rate Calculator
    • 2.2 Publishing policies
      • 2.2.1 Guiding principles for disseminating Cochrane Reviews
      • 2.2.2 Cochrane Reviews (converting Protocols, updating/withdrawing)
        • 2.2.2.1 Who is the audience for Cochrane Reviews?
        • 2.2.2.2 Policy on updating Cochrane Reviews and converting Protocols
        • 2.2.2.3 Policy on withdrawing Cochrane Protocols and Reviews
        • 2.2.2.4 Plain language summaries
        • 2.2.2.5 Process in the event of serious errors in published Cochrane Reviews
        • 2.2.2.6 Access to archived Cochrane Reviews
      • 2.2.3 The Cochrane Database of Systematic Reviews
      • 2.2.4 Rationale for requiring Cochrane authors to publish in the Cochrane Database of Systematic Reviews first
      • 2.2.5 Publication of versions of Cochrane Reviews in print journals
        • 2.2.5.1 Derivative publications
        • 2.2.5.2 Responding to feedback
        • 2.2.5.3 ‘House rules’ for responding to feedback on the Internet
      • 2.2.6 Royalties
      • 2.2.7 Copyright (Licence for Publication forms)
        • 2.2.7.1 Permission to republish Cochrane material in print
        • 2.2.7.2 Copyright permission request form
        • 2.2.7.3 Licence for Publication - Cochrane Reviews
        • 2.2.7.4 Licence for Publication - Protocols for Cochrane Reviews
        • 2.2.7.5 Declarations of Interest by Cochrane authors
        • 2.2.7.6 Guideline for deceased authors
        • 2.2.7.7 Addendum to licence for publication of a WHO manuscript as a Cochrane Protocol or Review
      • 2.2.8 Access options for The Cochrane Library
      • 2.2.9 Use of the Cochrane logo
        • 2.2.9.1 Introduction
        • 2.2.9.2 Who can use the logo without explicit permission?
        • 2.2.9.3 Who should seek permission before using the symbol (with or without text)?
        • 2.2.9.4 Use of modified version of the logo
        • 2.2.9.5 What if someone seems to be using the symbol (with/without text) or name inappropriately?
      • 2.2.10 Translation policies
      • 2.2.11 How to cite our products
      • 2.2.12 Withdrawal or suspension of complimentary copies of The Cochrane Library
      • 2.2.13 Access to the Parent Database
      • 2.2.14 Cochrane-Wiley book series proposals
      • 2.2.15 Guidelines for managing reviews with overlapping scope
    • 2.3 Commercial sponsorship policy
      • 2.3.1 Colloquium sponsorship
    • 2.4 Annual prizes and awards
      • 2.4.1 Thomas C Chalmers Award
      • 2.4.2 Chris Silagy Prize
      • 2.4.3 Bill Silverman Prize
      • 2.4.4 Kenneth Warren Prize
      • 2.4.5 Anne Anderson Award
    • 2.5 Fellowships, scholarships and bursaries
      • 2.5.1 Cochrane Complementary Medicine Field Bursary Scheme
      • 2.5.2 Aubrey Sheiham Public Health and Primary Care Scholarship
      • 2.5.3 Cochrane Visiting Fellowship (discontinued)
  • 3. OPERATIONS
    • 3.1 Steering Group
      • 3.1.1 Membership
      • 3.1.2 Election procedure
      • 3.1.3 Sub-committees of the Steering Group
      • 3.1.4 Advisory committees to the Steering Group
        • 3.1.4.1 Information Services Operations Committee (ISOC)
        • 3.1.4.1.1 Web Sites Committee (WSC)
        • 3.1.4.1.2 Cochrane Register of Studies (CRS) Project Board
        • 3.1.4.1.3 ReviewManager Advisory Committee (RAC)
        • 3.1.4.1.4 Archie Development Advisory Committee (ADAC)
      • 3.1.5 Attendance at Steering Group meetings
    • 3.2 Cochrane Review Groups
      • 3.2.1 Introduction
        • 3.2.1.1 Aims of this section
        • 3.2.1.2 Principles that make Cochrane Review Groups work
        • 3.2.1.3 Registration as part of The Cochrane Collaboration
        • 3.2.1.4 How Cochrane reviews are published
        • 3.2.1.5 Core functions of Cochrane Review Groups
      • 3.2.2 How Cochrane Review Groups form
        • 3.2.2.1 What can I do?
        • 3.2.2.2 Exploring areas of common interest
        • 3.2.2.3 Contacting Cochrane Centres
        • 3.2.2.4 Organizing exploratory meetings
        • 3.2.2.5 Managing the politics
        • 3.2.2.6 Considering the scope
        • 3.2.2.7 Making the commitment
        • 3.2.2.8 The Co-ordinating Editor
        • 3.2.2.9 The Managing Editor (formerly 'Review Group Co-ordinator')
        • 3.2.2.10 Forming an editorial team
        • 3.2.2.11 The Feedback Editor
        • 3.2.2.12 Identifying authors
        • 3.2.2.13 Developing a specialized register of RCTs
        • 3.2.2.14 Registering a Cochrane Review Group
        • 3.2.2.15 Ensuring computing support
        • 3.2.2.16 Publicising the Group’s existence
      • 3.2.3 Producing and updating reviews
        • 3.2.3.1 Fostering collaboration and co-operation
        • 3.2.3.2 Developing protocols
        • 3.2.3.3 Increasing trials register coverage
        • 3.2.3.4 Providing technical support
        • 3.2.3.5 Developing guidelines
        • 3.2.3.6 Managing areas of common interest
        • 3.2.3.7 Providing ‘space’ to conduct systematic reviews
        • 3.2.3.8 Maintaining communication
      • 3.2.4 Managing expectations: what does The Cochrane Collaboration expect of authors, and what can authors expect of The Cochrane Collaboration?
      • 3.2.5 Personnel and support
        • 3.2.5.1 Getting started
        • 3.2.5.2 The resources
        • 3.2.5.3 The authors
        • 3.2.5.4 Personnel and structure of a Cochrane Review Group
        • 3.2.5.5 Planning funding
      • 3.2.6 Maintaining and managing a Cochrane Review Group
        • 3.2.6.1 Establishing a refereeing policy
        • 3.2.6.2 Policy on default statistics
        • 3.2.6.3 Non-performance of authors
        • 3.2.6.4 Avoiding duplication of reviews and protocols
        • 3.2.6.5 Internal Cochrane Review Group policies
        • 3.2.6.6 Dealing with conflicts within Groups
        • 3.2.6.7 Liaising with Fields and Methods Groups
        • 3.2.6.8 Maintaining an active list of authors and other contributors
        • 3.2.6.9 Producing a newsletter
        • 3.2.6.10 Reviewing the scope of the Cochrane Review Group
        • 3.2.6.11 Performance and quality assessment of Cochrane Review Groups
      • 3.2.7 Conclusion
      • 3.2.8 Acknowledgements
      • 3.2.9 Appendices
        • 3.2.9.1 Agenda for an exploratory meeting to discuss formation of a Cochrane Review Group
        • 3.2.9.2 Report of an exploratory meeting
        • 3.2.9.3 Checklist for application to register a Cochrane Review Group
        • 3.2.9.4 Example covering letter for application to register with The Cochrane Collaboration
        • 3.2.9.5 Recruitment of a Managing Editor
        • 3.2.9.6 Recruitment of a Trials Search Co-ordinator
        • 3.2.9.7 Co-ordinating Editor job description and expectations of role
    • 3.3 Centres
      • 3.3.1 Centre Branches: Core functions and accountability mechanisms
      • 3.3.2 Guiding principles for Centre Directors and Staff
      • 3.3.3 Generic position description for a Centre Director
    • 3.4 Fields
      • 3.4.1 Introduction
      • 3.4.2 The definition and role of Cochrane Fields
        • 3.4.2.1 Definition of a Cochrane Field
        • 3.4.2.2 The role of Cochrane Fields
        • 3.4.2.3 Core functions of Fields
      • 3.4.3 How Fields work
        • 3.4.3.1 The functioning of Cochrane Fields
        • 3.4.3.2 Identifying trials and developing a Specialised Register
        • 3.4.3.3 Ensuring proper representation on Cochrane Review Groups
        • 3.4.3.4 Acting as a channel of communication
        • 3.4.3.5 Promoting the health care interests of Fields within The Cochrane Collaboration
        • 3.4.3.6 Promoting the aims and work of The Cochrane Collaboration within the Field
        • 3.4.3.7 Preparing specialised databases of systematic reviews
        • 3.4.3.8 Identifying funding opportunities
      • 3.4.4 Establishing a Cochrane Field
        • 3.4.4.1 Understanding the differences between Fields and other Cochrane entities
        • 3.4.4.2 Preparing for and holding a formal exploratory meeting
        • 3.4.4.3 Registering with The Cochrane Collaboration
        • 3.4.4.4 Designing the structure of the Field
        • 3.4.4.5 Obtaining resources for Fields
      • 3.4.5 The registration process
      • 3.4.6 Managing the module
      • 3.4.7 Monitoring the performance of a Cochrane Field
      • 3.4.8 The Consumer Network
      • 3.4.9 Acknowledgements
    • 3.5 Methods Groups
      • 3.5.1 The role of Methods Groups
        • 3.5.1.1 Providing policy advice
        • 3.5.1.2 Serving as a forum for discussion
        • 3.5.1.3 Ensuring that the Group functions as part of The Cochrane Collaboration
        • 3.5.1.4 Providing training (elective core function)
        • 3.5.1.5 Hosting a network of CRG-based methods individuals (elective core function)
        • 3.5.1.6 Providing peer review (elective core function)
        • 3.5.1.7 Providing specialist advice (elective core function)
        • 3.5.1.8 Contributing to new products or lines of activity (elective core function)
        • 3.5.1.9 Contributing to software development (elective core function)
        • 3.5.1.10 Conducting Cochrane methodology reviews (elective core function)
        • 3.5.1.11 Contributing to the Cochrane Methodology Register (elective core function)
        • 3.5.1.12 Helping to monitor and improve the quality of Cochrane Reviews (elective core function)
        • 3.5.1.13 Conducting methodological research (elective core function)
        • 3.5.1.14 Communicating Cochrane methodology to external organizations (elective core function)
      • 3.5.2 Registration and accountability
      • 3.5.3 Co-ordination of Methods Groups
      • 3.5.4 Improving methodological support in The Cochrane Collaboration
      • Annex: Annual survey of members
  • APPENDIX 1: Co-publication agreements/ correspondence with journal editors re publishing Cochrane reviews
    • A1.1. Co-publication agreements
    • A1.2. Correspondence from journal editors re publishing Cochrane reviews
  • APPENDIX 2: Monitoring and Registration Committee
    • A2.1. Introduction
    • A2.2. Core functions of the Monitoring and Registration Committee
    • A2.3 Composition of the Monitoring and Registration Committee
    • A2.4 Objectives of the Monitoring and Registration Committee
    • A2.5 Registration
      • A2.5.1 Objective of the registration process
      • A2.5.2 Registration criteria
      • A2.5.3 Registration process
      • A2.5.4 Ongoing registration issues
    • A2.6 Monitoring
      • A2.6.1 Objectives of the monitoring process
      • A2.6.2 Principles of monitoring
      • A2.6.3 Monitoring process
      • A2.6.4 Criteria for monitoring
      • A2.6.5 Criteria for identifying entities about which the Monitoring and Registration Committee should be concerned
      • A2.6.6 Strategies to help those entities experiencing particular difficulties
      • A2.6.7 Examples of good practice
    • A2.7 De-registration of an entity
      • A2.7.1 Principles of de-registration
      • A2.7.2 Criteria for de-registration
      • A2.7.3 Process for de-registration
    • Annex A2.A: Requirements for registration by type of entity
      • Checklist for registering a new Centre
      • Checklist for registering a new Cochrane Review Group (CRG)
      • Checklist for registering a new Field
      • Checklist for registering a new Methods Group
    • Annex A2.B: Registration process for new entities
    • Annex A2.C: Major and minor changes to entities
  • APPENDIX 3: Contact people at John Wiley & Sons Limited (Wiley-Blackwell)
  • APPENDIX 4: The Cochrane Collaboration supports prospective registration of clinical trials
Share this
  • About us
    • » History
    • » Evidence-based health care
    • » Newcomers' guide
    • » Frequently asked questions (FAQ)
    • » Funding & support
    • » How to donate
    • » Get involved
    • » Reports
    • » Our policies
    • » Our principles
    • » Awards, scholarships & funding initiatives
    • » Cochrane Consumer Network (CCNet)
    • » The Campbell Collaboration
  • Cochrane Reviews
    • » Browse free summaries
    • » About The Cochrane Library
    • » The Cochrane Library (Full-text)
    • » Top 50 Reviews
    • » Evidence Aid project
    • » Registering Titles
    • » Other Cochrane publications
    • » Glossary of Cochrane terms
  • News & Events
    • » Current news
    • » Opportunities & Jobs
    • » Other job opportunities
    • » Cochrane Collaboration Calendar
    • » Official Blog
    • » Discussion lists
    • » Cochrane in the News
    • » Newsletters
    • » Colloquia
    • » Homepage features
    • » RSS feeds
    • » Workshops
    • » Select evidence-based health care events
  • Training
    • » For authors & MEs
    • » For Cochrane Library Users
    • » Cochrane Handbook
    • » Glossary of Cochrane terms
  • Multimedia
    • » Video
    • » Podcasts
    • » Multimedia from Cochrane Colloquia and meetings
    • » Webinars
  • Contact
    • » Operations Unit and Editorial Unit
    • » Steering Group and Subgroups
    • » Cochrane Centre for your country
    • » Centres and Branches
    • » Review Groups
    • » Methods Groups
    • » Fields and Networks
Cochrane

Copyright © 2013 - The Cochrane Collaboration

  • About this site
  • Disclaimer
  • Privacy
  • Site map
  • Site index
  • Login